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Interleukin-8  (IL-8) is a  neutrophil  chemotactic  and  activat- 
ing  cytokine  that is  produced  in response  to  several  stimuli. 
Because  monocytic  cells are  important  producers  of IL-8, 
we investigated  whether  interferon-7  (IFN-T), a  potent  in- 
ducer  of  activation  and  differentiation  of  mononuclear 
phagocytes, affected IL-8 expression  in  this  cell  lineage. 
We found a low constitutive  level  of IL-8 mRNA  expression 
that was upregulated  by IFN-7 in a dose-  and time-depen- 
dent  manner  and  via  a  protein-synthesis-dependent  pro- 
cess  in  the  human  monocytic  cell  line U937. IL-8 protein 
secretion was also stimulated  by IFN-7. Nuclear  run-on  ex- 
NTERLEUKIN-8  (IL-8), originally described as a neu- 
trophil  chemotactic  and activating cytokine,l*6  also pos- 
sesses chemotactic activity  for basophils and T lympho- 
cytes, both  in  vitro and in  Monocytic  cells seem to 
be the  predominant  source of IL-8,1,2,9  although a wide va- 
riety of cells, including fibroblasts,IO,’’  endothelial and epi- 
thelial  cell^,'^"^ keratinocytes,1°,’5  condrocytes,L6  lympho- 
cytes,”  and  human  tumor  cell lines18x19  can  express IL-8 
mRNA and produce the protein  in  response to  tumor ne- 
crosis factor-a (TNF-(U),  IL-l  ,10313,18 mitogens, lectins, and 
viruses.  13,20 
IFN--, is a product of activated T lymphocytes and natu- 
ral killer cells with antiproliferative, antiviral and  immuno- 
modulatory properties.21  This cytokine is a potent  inducer 
of activation  and differentiation  of  mononuclear  phago- 
cyte~,~~,~~  manifested  by  increase  in  class  I1 HLA  anti- 
gen~~~,~~  and transferrin receptor expression,26  toxic oxygen 
derivatives and nitric  oxide  prod~ction,~”~~  tumoricidal ac- 
tivity,22,28  and  regulation  of  cytokine  prod~ction.~~,~~-~~ 
IFN--,  is inhibitory for normal myelopoie~is~~  and  for the in 
vitro growth of myeloid and monocytoid human leukemia 
cell lines.33  Upon exposure to IFN-7, normal and leukemic 
promyelocytic and promonocytic cells differentiate  in  vitro 
along the monocytic  The  human  promono- 
cytic leukemia  line  U93735 responds  to IFN--,  with  de- 
creased proliferation and  the expression of  Ig-Fc receptors 
(FcRs) and HLA-DR antigens, as well as antibody-depen- 
dent cellular cytotoxicity and hydrogen peroxide produc- 
tion.36-38 
IFN--,  exerts opposite  effects on IL-8  gene expression 
and/or protein  secretion depending on  the  lineage of the 
target cells.  Inhibitory effects  of  IFN--,  on IL-8 were re- 
ported  in  fib rob last^^^ and thymic epithelial cells,@  whereas 
enhancing activity has been shown in  keratino~ytes’~  and 
human gastric cancer cell lines.”  Because monocytic cells 
can respond to IFN--, and they are important producers of 
IL-8, it was of interest  to establish whether IFN--,  could 
affect  IL-8 expression in this cell lineage. In this  report, we 
show that IFN--, is an inducer of IL-8 mRNA accumulation 
and protein secretion by the monocytic cell line U937, and 
that this  induction  occurs  via a protein-synthesis-depen- 
dent process. Furthermore, we show that  the  enhancement 
of IL-8 mRNA expression by IFN-y  is controlled primarily 
at a posttranscriptional level. 
I 
MATERIALS AND  METHODS 
Cell culture.  The  human  promonocytic cell line U937, oripi- 
nally established from a patient with histiocytic lymphoma,3s was 
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periments  showed  that the IL-8 gene was transcriptionally 
active in  control  cells  and that IFN-7 did  not  enhance  the 
transcriptional  activity.  The  increase  in  IL-8 mRNA  by IFN- 
7 was concomitant with the stabilization  of  the mRNA  and, 
therefore,  controlled  primarily  at  a  posttranscriptional 
level.  These  results  represent  the first  evidence that IFN-7 
upregulates IL-8 gene  expression  in cells of the monocytic 
lineage,  and  show the involvement  of  posttranscriptional 
mechanisms  in  the induction  of  IL-8 mRNA. 
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cultured at 37’C  in a 5% CO2-humidified atmosphere in RPM1 1640 
(Advanced  Biotechnology, Columbia,  MD), supplemented  with 
100 U/mL penicillin,  100 U/mL streptomycin, 2 mmol/L gluta- 
mine, and 10% heat-inactivated  fetal calf  serum  (FCS) (HyClone 
Laboratories,  Logan, UT), hereafter referred to as complete me- 
dium (CM). Exponentially growing cells were centrifuged, resus- 
pended at a concentration  of 8 X  lo5  cells/mL of  medium,  and 
plated in  15-cm Lux plates (Miles Scientific, Wapersville, CA) in 
fresh CM alone or supplemented with the indicated doses of recom- 
binant human IFN-7 (specific activity 2.02  X  IO’  U/mg),  kindly 
provided by Dr Creig Reynolds (BRMP, National  Cancer  Institute- 
Frederick Cancer Research and Development  Center,  Frederick, 
MD).  Cells and  supernatants  were  harvested  at predetermined 
times and spun at 1,400 rpm for 5 minutes. Cell-free supernatants 
were collected and tested for  cytokme release; cell pellets were ex- 
tracted for total  RNA. For mRNA-synthesis inhibition,  actinomy- 
cin D (DAct; Sigma Chemical CO,  St Louis, MO) was dissolved in 
ethanol at  I  mg/mL and used at a final concentration  of 5 pg/mL 
for the  times specified in  the text. For protein-synthesis inhibition 
experiments,  cycloheximide (Sigma) was used at 10 pg/mL final 
concentration. All the reagents were demonstrated by the  Limulus 
amebocyte test  (MA  Bioproducts,  Walkersville, MD; sensitivity 
0.06 EU/mL)  to  be  endotoxin free. 
Northern blot analysis.  Cells were lysed in RNAzol (Tel-Test, 
Inc, Friendswood, TX)  and total  RNA  was purified according to 
the manufacturer’s instructions. Twenty micrograms  of  total  RNA 
from each sample was electrophoresed under denaturing  conditions 
on a  1.2% agarose gel containing 2.2  mol/L formaldehyde, trans- 
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E  IFNy Ulml  mmol/L CaC12  and 20 pL of I  U/mL DNase I (Promega, Gaithers- 
U  were  isolated  by  guanidine  isothiocyanate/phenolchloroform 
burg, MD) were added to the  mixture and  the incubation allowed 
-2 ?-A-=  to  continue  for IO  minutes at 29°C. Labeled elongated transcripts 
Q)  ocvmo  m  method.  Equal  amounts of  acid-precipitable  radioactivity  were 
IV)mrCVV)  added in  I  mL of Hybrizol (Oncor)  to  Nytran  membranes  on  which 
5 pg of linearized plasmid containing the full-length IL-8 cDNA. 
chicken @-actin  (I  .8 kb  Nindlll fragment), and  Hindlll linearized 
pUC19 were immobilized usingaslot blot apparatus(GIBC0-BRL, 
Gaithersburg,  MD).  Hybridization  was performed at 42’C  for 40 
hours, and filters were then washed as described for Northern  anal- 
ysis before an additional washing was performed  for  15 minutes 
at room  temperature  in 2X  SSC containing  1 pglmL of  RNase A 
(Boehringer). Filters were then exposed for autoradiography. 
RESULTS 
IL-8 mRNA e,rpre.mion  and  cytokine prodwtion.  To de- 
termine whether the  U937  cell line responded to IFN-r  with 
Fig 1.  Induction  of IL-8 mRNA expression  by different doses  of 
IFN-7. U937 cells were cultured  for 24 hours in the presence  of  in- 
creasing  concentrations  of  IFN-7 before total RNA was isolated  and 
analyzed  for  IL-8 mRNA  expression.  The same filter was subse- 
quently  rehybridized  with G3PDH to control that equal  amounts  of 
RNA were loaded  in  each  lane.  These  data are representative of 
three experiments. 
ferred onto Nytran  membranes  (Schleicher & Schuell Inc. Keene, 
NH), and cross-linked by UV irradiation, as  previously described.23 
Filters were prehybridized for 6 hours at 42°C in Hybrisol solution 
(Oncor Inc. Gaithersburg. MD)  and hybridized overnight with 2 X 
IO6 cpm/mL of  32P-labeled  probe. Membranes were then washed 
three times at room temperature for  IO minutes in 2X  SSC, 0.1% 
sodium dodecyl sulfate (SDS) and twice at 60°C for I5 minutes in 
0.2X  SSC. 0. l%  SDS. before being autoradiographed using Kodak 
XARJ film (Eastman  Kodak,  Rochester,  NY)  and  intensifying 
screens at -80°C.  Probes were labeled by random priming reaction 
using a commercial kit (Boehringer Mannheim Biochemicals. Indi- 
anapolis,  IN) and  [d2P]dCTP  (3,000 Ci/mmol: Amersham Corp. 
Arlington Heights, IL). The  specific activity was always higher than 
IO9 cpmlpg.  For IL-8 detection. the IL-8 full-length cDNA, kindly 
provided by Dr K.  Matsushima  (Kanazawa University Cancer In- 
stitute, Kanazawa, Ishikawa-ken. Japan). was used; glyceraldehyde- 
3 phosphate dehydrogenase mRNA levels were assessed by  using 
the  human  G3PDH probe from Clontech  (Palo  Alto, CA). When 
needed, the autoradiographs were scanned using a light densitome- 
ter. 
Cytokine determination.  IL-8 release from U937 cells was de- 
termined by enzyme-linked immunosorbent assay (ELISA; Amers- 
ham), that allows detection of IL-8 concentration  above  30 pg/mL. 
Nuclear run-on.  Nuclear run-on  experiments were performed 
as previously described.23  Briefly, nuclei were isolated from 5 X  IO’ 
cells/sample by  lysis in 4 mL of lysis buffer (IO mmol/L Tris-Cl. 
pH 7.4,  IO mmol/L NaCI, 3 mmol/L MgCI2, 0.5% Nonidet P-40 
[Sigma]) for IO minuteson ice. Nuclei were collected after  centrifu- 
gation at 800 rpm for 5 minutes at 4”C, resuspended in  100  pL of 
freezing buffer (50  mmol/L  Tris-Cl pH 8.3,40% glycerol, 5 mmol/ 
L MgCI2),  and stored at -70°C  until use. In vitro  RNA elongation 
was performed  by  adding 100 pL of 2X  transcription  buffer (20 
mmol/LTris-Cl, pH  8.0,300  mmol/LKCI,  IO mmol/L MgCI2,  200 
mmol/Lsucrose, 20% glycerol. I  mmol/L dithiothreitol, 0.5 mmol/ 
L each of adenosine  triphosphate,  guanosine  triphosphate,  cytidine 
triphosphate and  100  pCi of 800  Ci/mmol [n3*P]uridine  triphos- 
phate  (Amersham)  to 100  pL of nuclei suspension, and  the  mixture 
was incubated at 29°C for 30 minutes.  Twenty  microliters of  200 
changes in IL-8 mRNA expression, U937 cells were treated 
with  increasing concentrations of IFN-7. Total RNA was 
harvested 24 hours  after treatment, a time point at which 
several markers  induced  by  IFN-7 are detectable in U937 
 cell^.^"^' Figure  I  shows the results of a representative ex- 
periment. Low,  basal expression of IL-8 mRNA was detect- 
able in untreated U937 cells. IFN-r  caused a dosedepen- 
dent increase of IL-8 mRNA, and as little as 5 U/mL were 
sufficient to induce a major increase in mRNA. Plateau lev- 
els were reached with 250 U/mL of IFN-7, and this concen- 
tration was used in subsequent experiments. 
To  determine  the  kinetics  of  the  induction  of  IL-8 
mRNA.  Northern  blot  analysis was  performed  on total 
RNA  extracted  from  U937  cells incubated  for different 
lengths of time in medium  alone  or supplemented with 250 
IFNy 
IL-8 
G3PDH - 
Fig 2.  Kinetics  of  IFN-7-mediated  upregulation  of  11-8 mRNA. 
U937  cells werestimulated with 250 U/mLof IFNyfortheindicated 
times. Total RNA was extracted and  Northern  blot  analysis  was 
performed  as  described  in  Materials and Methods. G3PDH levels 
were determined to ensure that comparable  amounts  of  RNA  were 
loaded in each  lane.  These  data are  representative  of  three experi- 
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Fig 3.  11-8 production  induced  by  IFN-7. U937 cells were cul- 
tured at 8 X  10' cells/ml in the (A)  presence  or  (0)  absence  of  250 
U/mL of IFN-y. supernatants  were collected at different  times and 
the secreted 11-8 measured by  ELISA.  The results,  expressed  as 
picograms  of  IL-8/mL per 8 X  10"  cells/mL,  represent the average 
of three experiments  performed.  The SE was less than 10%  of the 
mean. 
U/mL of IFN-y. A significant and maximal increase in IL- 
8 mRNA above the steady-state level was observed at 18 
hours and 24 hours of  stimulation,  gradually decreasing 
thereafter (Fig 2). In conclusion, these results provide clear 
evidence that IFN-y can upregulate IL-8 mRNA expression 
in cells of the monocytic lineage. 
To investigate whether the induction of IL-8 mRNA was 
associated with cytokine secretion, supernatants from cul- 
tured cells were harvested at various  times  after  stimulation 
with 250 U/mL of IFN-y and assayed for IL-8 protein levels 
by  ELISA.  Levels  of secreted IL-8 rapidly increased between 
12 and 36 hours in response to stimulation, reaching a pla- 
teau by 36 hours (Fig 3). We conclude that IL-8 mRNA ac- 
cumulation is associated with IL-8 secretion. 
Control  of  IL-8  gene  expression.  To  investigate  the 
mechanisms  regulating the induction  of  IL-8  mRNA by 
IFN-y, nuclear run-on transcription  experiments were per- 
formed  on  cells treated  with  medium  alone or  supple- 
mented with 250 U/mL of IFN-y  for different lengths of 
time. Figure 4 depicts the results of a representative experi- 
ment.  Constitutive  transcriptional  activity of the IL-8 gene 
was detectable in medium-treated cells, but  it  was not mod- 
ified  by  treatment with IFN-y, whereascell stimulation with 
PMA (30 nmol/L) for 2 hours caused an increase in IL-8 
gene transcriptional rate, in  accord  with what has been pre- 
viously  reported  in  promonocytic  cells.4'  Our  results 
showed that  the constitutive  transcriptional activity of the 
IL-8 gene was not affected  by IFN-y and suggested that  the 
observed upregulation  of IL-8 mRNA by  IFN-y  involved 
posttranscriptional events. 
To  assess the possibility that induction of IL-8 accumula- 
tion by  IFN-y  was the result of mRNA stabilization, the 
half-life of IL-8 mRNA was measured. U937 cells were in- 
cubated  for 18 hours with medium  alone or supplemented 
with 250 U/mL of IFN-y and treated with 5 ccg/mL of DAct 
for various lengths of time  to  block further RNA transcrip 
tion. We found that IL-8 mRNA decayed with different ki- 
netics in untreated and treated cells after the inhibition of 
RNA synthesis (Fig 5). In fact, the levels of IL-8 mRNA in 
medium-treated cells were already decreased by about 50% 
after 40 minutes of exposure to DAct, and became almost 
undetectable  after 6 hours  (TlI2  40 minutes). IFN-y treat- 
ment increased the stability of IL-8 mRNA threefold (T1/2 
120 minutes).  Similar  differences in  the half-life  of  IL-8 
mRNA were observed in three  independent  experiments. 
These  results  indicated  that  the  enhancement  of  IL-8 
mRNA by IFN-y was associated with the stabilization ofthe 
mRNA. 
To determine  the  requirement  for active protein synthesis 
in IL-8 mRNA  induction  by IFN-y, U937 cells were incu- 
bated for 18 hours with 250 U/mL of IFN-y in the presence 
or absence of the protein-synthesis inhibitor cycloheximide 
(CHX; IO  pg/mL). As depicted by the results shown in Fig 6 
that  are  representative  of three different experiments, the 
addition  of CHX  to  IFN-y-treated  cells completely pre- 
vented the upregulation of IL-8 mRNA expression. These 
results show that  the  stimulatory effects of IFN-y are depen- 
dent  on  de  novo protein synthesis. 
DISCUSSION 
Induction of IL-8 mRNA and protein secretion has been 
observed in monocytic cells in response to lipopolysaccha- 
ride (LPS),'*20.42  IL-l, TNF-cu,~.~~  phorbol esters or  lectins 
(Con A, PHA)?0s41  IL-7,43  granulocyte-macrophage colony- 
stimulating  factor  (GM-CSF),"4 and, recently, IL-2.4' 
The present study provides the first evidence of the ability 
of IFN-y to upregulate IL-8 mRNA expression and protein 
secretion in human monocytic cells. Exposure of U937 cells 
to relatively low amounts of IFN-y (5 U/mL) induces IL-8 
mRNA  accumulation, that reaches maximal levels after 18 
E  IFNy 
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Fig 4.  Nuclear  run-on  transcription  analysisof  11-8 gene in U937 
cells. Nuclei  were isolated  from medium-treated  cells and  from  cells 
stimulated  for  different  lengths  of  time with IFN-7 (250  U/ml) or 2 
hours with  PMA  (30  nmol/L),  and  nuclear  run-on  experiments  were 
performed  as  described  in Materials and  Methods.  Actin  levels  of 
transcription were determined  as  an  internal  control; pUcl9  served 
as  a  control  for  nonspecific  hybridization. 540  BOSCO  ET  AL 
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Fig 5.  Effects  of IFNy on IL-8 mRNA stability. U937  cells were 
stimulated  for 18  hours with IFN-y (250 U/mL). mRNA  expression 
was tested immediately or after incubation  with DAct (5  rg/mL) for 
1,2,4, and 6 hours.  Densitometric  analysis  of  signal  intensities  in 
untreated (0)  and treated cells (A)  are expressed  as  amounts  rela- 
tive to G3PDH signal  intensities. 
to  24 hours oftreatment with 250 U/mL of IFN--,,  decreas- 
ing thereafter. Accordingly, a time-dependent  increase in 
IL-8 secretion is detectable upon  stimulation  with 250 U/ 
mL of  IFN--,,  reaching a plateau by 36 hours. 
A single cytokine can  act  as  both a positive and negative 
signal depending on  the  lineage and stage of differentiation 
of the cell, because single receptors may couple to multiple- 
signal transduction pathways.”  IFN--, has been shown to 
enhance IL-8 mRNA  and/or protein accumulation in hu- 
man keratin~cytes’~  and  in human gastric cancer cell  lines’’ 
in synergy  with TNF-a, whereas inhibitory effects of IFN--, 
on IL-8 production  induced by TNF-a or IL-la have been 
reported in human fibroblasts” and in human thymic epi- 
thelial cells,40  respectively.  We have recently shown that IL- 
2  induces  IL-8  mRNA  and bioactivity  in  human fresh 
monocytes and  that  IFN--,  has suppressive effects on  the 
basal and 1L-2-induced expression and secretion of IL-8.“5 
Similarly, IFN--,  effectively inhibits the induction of  IL-8 
elicited by  IL-IS  in  m0nocytes.4~  Therefore, the  data pre- 
sented here provide the first evidence ofthe  ability of IFN--, 
by  itself to upregulate  IL-8 gene expression.  Because the 
U937 is a promonocytic cell line, we can speculate that IFN- 
7 may exert opposite effects on IL-8 expression in cells of 
the monocytic lineage at different stages of differentiation, 
stimulatory in monocyte precursors and inhibitory  in  circu- 
lating monocytes. However, we cannot rule out  the  possibil- 
ity that  the  transformed nature of the U937 cells, or, alter- 
natively, their active proliferation, may be involved in  their 
response to IFN--,. 
A differential response of  U937 cells and monocytes to 
IFN--,  has been shown for other genes.  In  mature mono- 
cytes, IFN--, stimulates  the  release of IL-IS  and  TNF-a,)’.” 
both of which can  induce IL-8 mRNA expression and pro- 
tein producti~n.’*~~~~’  On  the  contrary, we found that U937 
promonocytic cells do not secrete IL-IP and  TNF-a  after 
stimulation with  IFN--, (data not shown). These results also 
indicate that  the  stimulatory effects  of  IFN--,  on IL-8  ex- 
pression in U937 cells are not mediated by the secretion of 
these two cytokines. Nevertheless, the control of  IL-8  ex- 
pression in U937 cells is quite complex, and we  have pre- 
liminary evidence that IL-4 can  inhibit  the induction of IL- 
8 by IFN--, (M.C. Bosco, manuscript in preparation). The 
inhibitory effects of  IL-4 are not  stimulus-dependent  be- 
cause IL-4-induced downregulation of IL-8 mRNA expres- 
sion and protein synthesis was shown in LPS-  TNF-  or  IL- 
l-stimulated   monocyte^.^^ 
The transcriptional regulatory elements present in the 5’ 
flanking region of the  human IL-8 gene have been studied 
by several laboratories and the sequences involved in regu- 
lating gene expression in response to various cytokines in 
different  cells  have  been  defined.14.19,20.46  Because  IL-8 
mRNA  contains  several AU-rich  sequences in  its 3’  un- 
translated  region’  that  have  previously  been  shown  to 
render  mRNA  transcripts  more  susceptible to  degrada- 
tion,’’’  IL-8 expression may also be controlled at  the  level  of 
mRNA stabilization. Transcriptional  activation of the IL-8 
gene is the primary mechanism of regulation of IL-8 mRNA 
expression reported to  date  in cells belonging to several lin- 
eages and in response to  many  signals.’2.’4.’9.39*46  For exam- 
ple, transcriptional regulation of the IL-8 gene by IFN--, has 
been shown in gastric cell lines” and fresh mon0cytes.4~  By 
contrast, here we have shown that IL-8 gene was transcrip 
tionally  active  in  unstimulated  U937  cells,  and  IFN--,, 
which augmented IL-8 mRNA, did not increase the tran- 
scriptional  activity,  suggesting  that  posttranscriptional 
events may  be  involved in  regulating mRNA  levels.  We 
found that, after blocking new RNA synthesis with DAct, 
CHX 
_y___ 
Fig 6.  Effects  of  CHX on  IFN-7-induced  upregulation  of 11-8 
mRNA expression. U937  cells were treated with 250  U/mL of  IFN- 
y in the presence or  absence  of  10  rg/mLof CHX and total RNA was 
extracted 18  hours later. Expression of G3PDH was determined to 
control  for  the amounts  of  RNA  loaded  in each  lane. IL-8  INDUCTION  BY  IFN-./  IN  MONOCYTIC  CELLS  541 
IL-8 mRNA decayed at a slower rate in IFN-y-treated than 
in medium-treated cells. These findings indicate that IFN-y 
enhanced the stability  of  IL-8  mRNA and  that  this effect 
may account for, or at least contribute to, the augmentation 
of IL-8 mRNA levels. The inhibition of IFN-y stimulatory 
effects  by  a protein-synthesis inhibitor shows requirement 
for de novo protein synthesis and suggests that IFN-y-in- 
ducible proteins may contribute to IL-8 mRNA stabiliza- 
tion. Posttranscriptional control of gene  expression  by IFN- 
y  has  been  previously  shown  in  murine,  peritoneal 
macrophages.48349  Furthermore, our data support a previous 
observation of regulation of  IL-8  mRNA induction at the 
posttranscriptional level in PMA-stimulated HL60 promy- 
elocyte~~’  and indicate that IL-8  gene  expression  can be con- 
trolled by  different molecular regulatory mechanisms in a 
cell-type  specific  manner, even if the cells are exposed to the 
same stimulus. 
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